Fluorine in PDB 7lg8: Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor
Enzymatic activity of Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor
All present enzymatic activity of Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor:
2.7.10.1;
Protein crystallography data
The structure of Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor, PDB code: 7lg8
was solved by
T.S.Beyett,
M.J.Eck,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
50.81 /
2.93
|
Space group
|
P 1 21 1
|
Cell size a, b, c (Å), α, β, γ (°)
|
55.654,
75.947,
150.978,
90,
94.41,
90
|
R / Rfree (%)
|
23.5 /
27
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor
(pdb code 7lg8). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor, PDB code: 7lg8:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 7lg8
Go back to
Fluorine Binding Sites List in 7lg8
Fluorine binding site 1 out
of 4 in the Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1101
b:53.9
occ:1.00
|
F36
|
A:VNS1101
|
0.0
|
53.9
|
1.0
|
C35
|
A:VNS1101
|
1.3
|
43.9
|
1.0
|
C37
|
A:VNS1101
|
2.3
|
47.0
|
1.0
|
C34
|
A:VNS1101
|
2.4
|
40.0
|
1.0
|
N
|
A:LEU777
|
3.2
|
39.2
|
1.0
|
C
|
A:ARG776
|
3.4
|
42.5
|
1.0
|
CA
|
A:LEU777
|
3.4
|
36.8
|
1.0
|
O
|
A:ARG776
|
3.5
|
48.0
|
1.0
|
C38
|
A:VNS1101
|
3.6
|
47.2
|
1.0
|
C33
|
A:VNS1101
|
3.6
|
44.3
|
1.0
|
CB
|
A:LEU777
|
3.7
|
39.4
|
1.0
|
CB
|
A:MET790
|
3.9
|
37.3
|
1.0
|
O
|
A:CYS775
|
4.0
|
50.8
|
1.0
|
SD
|
A:MET790
|
4.0
|
43.1
|
1.0
|
CE
|
A:MET790
|
4.1
|
46.1
|
1.0
|
C
|
A:CYS775
|
4.1
|
48.0
|
1.0
|
C39
|
A:VNS1101
|
4.1
|
45.8
|
1.0
|
N
|
A:ARG776
|
4.1
|
46.7
|
1.0
|
CA
|
A:ARG776
|
4.2
|
43.4
|
1.0
|
CB
|
A:CYS775
|
4.2
|
39.3
|
1.0
|
CD1
|
A:LEU777
|
4.3
|
39.3
|
1.0
|
CG
|
A:MET790
|
4.6
|
43.2
|
1.0
|
OG1
|
A:THR854
|
4.6
|
41.3
|
1.0
|
CG
|
A:LEU777
|
4.7
|
40.4
|
1.0
|
C
|
A:LEU777
|
4.8
|
37.8
|
1.0
|
CA
|
A:CYS775
|
4.8
|
45.3
|
1.0
|
O
|
A:MET766
|
4.8
|
47.3
|
1.0
|
N03
|
A:VNS1101
|
4.9
|
40.6
|
1.0
|
C02
|
A:VNS1101
|
4.9
|
39.4
|
1.0
|
C09
|
A:VNS1101
|
4.9
|
45.1
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 7lg8
Go back to
Fluorine Binding Sites List in 7lg8
Fluorine binding site 2 out
of 4 in the Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1101
b:58.0
occ:1.00
|
F36
|
B:VNS1101
|
0.0
|
58.0
|
1.0
|
C35
|
B:VNS1101
|
1.3
|
54.3
|
1.0
|
C37
|
B:VNS1101
|
2.3
|
58.1
|
1.0
|
C34
|
B:VNS1101
|
2.4
|
51.0
|
1.0
|
N
|
B:LEU777
|
3.4
|
51.9
|
1.0
|
C
|
B:ARG776
|
3.5
|
55.0
|
1.0
|
CA
|
B:LEU777
|
3.6
|
51.1
|
1.0
|
C38
|
B:VNS1101
|
3.6
|
54.4
|
1.0
|
O
|
B:ARG776
|
3.6
|
50.1
|
1.0
|
C33
|
B:VNS1101
|
3.7
|
53.1
|
1.0
|
CB
|
B:MET790
|
3.8
|
47.9
|
1.0
|
CE
|
B:MET790
|
3.9
|
39.4
|
1.0
|
O
|
B:CYS775
|
3.9
|
48.4
|
1.0
|
SD
|
B:MET790
|
3.9
|
49.9
|
1.0
|
C
|
B:CYS775
|
4.0
|
45.0
|
1.0
|
CB
|
B:LEU777
|
4.0
|
55.4
|
1.0
|
CB
|
B:CYS775
|
4.1
|
40.6
|
1.0
|
N
|
B:ARG776
|
4.1
|
47.7
|
1.0
|
C39
|
B:VNS1101
|
4.1
|
57.1
|
1.0
|
CA
|
B:ARG776
|
4.2
|
52.4
|
1.0
|
CG
|
B:MET790
|
4.5
|
48.4
|
1.0
|
CD1
|
B:LEU777
|
4.5
|
57.4
|
1.0
|
OG1
|
B:THR854
|
4.5
|
48.9
|
1.0
|
CA
|
B:CYS775
|
4.7
|
44.2
|
1.0
|
C02
|
B:VNS1101
|
4.9
|
57.4
|
1.0
|
CG
|
B:LEU777
|
4.9
|
57.2
|
1.0
|
C09
|
B:VNS1101
|
5.0
|
50.5
|
1.0
|
N03
|
B:VNS1101
|
5.0
|
60.1
|
1.0
|
C
|
B:LEU777
|
5.0
|
52.4
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 7lg8
Go back to
Fluorine Binding Sites List in 7lg8
Fluorine binding site 3 out
of 4 in the Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F1101
b:54.5
occ:1.00
|
F36
|
C:VNS1101
|
0.0
|
54.5
|
1.0
|
C35
|
C:VNS1101
|
1.3
|
52.4
|
1.0
|
C37
|
C:VNS1101
|
2.3
|
55.0
|
1.0
|
C34
|
C:VNS1101
|
2.4
|
45.0
|
1.0
|
N
|
C:LEU777
|
3.2
|
49.6
|
1.0
|
CA
|
C:LEU777
|
3.4
|
46.4
|
1.0
|
C
|
C:ARG776
|
3.4
|
50.9
|
1.0
|
O
|
C:ARG776
|
3.6
|
47.9
|
1.0
|
C38
|
C:VNS1101
|
3.6
|
49.5
|
1.0
|
C33
|
C:VNS1101
|
3.7
|
48.0
|
1.0
|
CB
|
C:LEU777
|
3.7
|
44.9
|
1.0
|
O
|
C:CYS775
|
3.9
|
46.5
|
1.0
|
CB
|
C:MET790
|
4.0
|
46.9
|
1.0
|
CE
|
C:MET790
|
4.0
|
50.9
|
1.0
|
C
|
C:CYS775
|
4.0
|
43.5
|
1.0
|
SD
|
C:MET790
|
4.1
|
46.6
|
1.0
|
C39
|
C:VNS1101
|
4.1
|
48.6
|
1.0
|
N
|
C:ARG776
|
4.1
|
46.3
|
1.0
|
CA
|
C:ARG776
|
4.2
|
51.7
|
1.0
|
CB
|
C:CYS775
|
4.2
|
42.8
|
1.0
|
CD1
|
C:LEU777
|
4.3
|
47.5
|
1.0
|
OG1
|
C:THR854
|
4.6
|
45.3
|
1.0
|
CG
|
C:LEU777
|
4.7
|
46.4
|
1.0
|
CG
|
C:MET790
|
4.7
|
45.4
|
1.0
|
C
|
C:LEU777
|
4.8
|
45.1
|
1.0
|
CA
|
C:CYS775
|
4.8
|
44.1
|
1.0
|
C02
|
C:VNS1101
|
5.0
|
58.4
|
1.0
|
C09
|
C:VNS1101
|
5.0
|
51.4
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 7lg8
Go back to
Fluorine Binding Sites List in 7lg8
Fluorine binding site 4 out
of 4 in the Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Egfr (T79M/V948R) in Complex with Naquotinib and An Allosteric Inhibitor within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:F1101
b:57.1
occ:1.00
|
F36
|
D:VNS1101
|
0.0
|
57.1
|
1.0
|
C35
|
D:VNS1101
|
1.3
|
52.4
|
1.0
|
C37
|
D:VNS1101
|
2.3
|
56.0
|
1.0
|
C34
|
D:VNS1101
|
2.4
|
55.2
|
1.0
|
N
|
D:LEU777
|
3.2
|
49.1
|
1.0
|
C
|
D:ARG776
|
3.2
|
50.3
|
1.0
|
O
|
D:ARG776
|
3.4
|
51.7
|
1.0
|
CA
|
D:LEU777
|
3.5
|
50.7
|
1.0
|
C38
|
D:VNS1101
|
3.6
|
59.3
|
1.0
|
C33
|
D:VNS1101
|
3.6
|
59.2
|
1.0
|
CE
|
D:MET790
|
3.7
|
48.4
|
1.0
|
SD
|
D:MET790
|
3.7
|
49.9
|
1.0
|
O
|
D:CYS775
|
3.8
|
49.9
|
1.0
|
CB
|
D:MET790
|
3.8
|
54.3
|
1.0
|
C
|
D:CYS775
|
3.8
|
53.5
|
1.0
|
N
|
D:ARG776
|
3.9
|
58.6
|
1.0
|
CB
|
D:LEU777
|
3.9
|
56.9
|
1.0
|
CA
|
D:ARG776
|
3.9
|
49.8
|
1.0
|
CB
|
D:CYS775
|
4.0
|
50.6
|
1.0
|
C39
|
D:VNS1101
|
4.1
|
61.8
|
1.0
|
CG
|
D:MET790
|
4.4
|
49.5
|
1.0
|
OG1
|
D:THR854
|
4.5
|
53.0
|
1.0
|
CA
|
D:CYS775
|
4.6
|
47.8
|
1.0
|
CD1
|
D:LEU777
|
4.6
|
52.1
|
1.0
|
C
|
D:LEU777
|
4.9
|
56.7
|
1.0
|
N03
|
D:VNS1101
|
4.9
|
57.0
|
1.0
|
C09
|
D:VNS1101
|
5.0
|
54.2
|
1.0
|
CG
|
D:LEU777
|
5.0
|
53.0
|
1.0
|
C02
|
D:VNS1101
|
5.0
|
55.1
|
1.0
|
|
Reference:
T.S.Beyett,
C.To,
D.E.Heppner,
J.K.Rana,
A.M.Schmoker,
J.Jang,
D.J.H.De Clercq,
G.Gomez,
D.A.Scott,
N.S.Gray,
P.A.Janne,
M.J.Eck.
Molecular Basis For Cooperative Binding and Synergy of Atp-Site and Allosteric Egfr Inhibitors. Nat Commun V. 13 2530 2022.
ISSN: ESSN 2041-1723
PubMed: 35534503
DOI: 10.1038/S41467-022-30258-Y
Page generated: Fri Aug 2 08:52:34 2024
|